Financial report interval: 2026.03.30 - 2026.06.30
Preview: Chugai Pharmaceutical(CHGCY) predict that the Revenue is 2.109 B (+5.29%), Beat estimate;the EBIT is 993.57 M (+5.22%), Miss estimate.